| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/21/2005 | WO2004064739A3 Substrate detection assay |
| 04/21/2005 | WO2004045543A3 Functional and hyperfunctional sirna |
| 04/21/2005 | WO2004041156A3 Method for determining sensitivity to a bacteriophage |
| 04/21/2005 | WO2004040252A3 Molecules and methods using same for measuring non-transferrin bound iron |
| 04/21/2005 | WO2004038380A3 Screening methods for identification of efficient pre-trans-splicing molecules |
| 04/21/2005 | WO2003107270A3 Metabolic phenotyping |
| 04/21/2005 | WO2003106639A3 Recombination of nucleic acid library members |
| 04/21/2005 | WO2003087772A3 Method for detecting low concentrations of a target bacterium that uses phages to infect target bacterial cells |
| 04/21/2005 | WO2003060471A3 Diagnosis and treatment for immunoglobulin e (ige) implicated disorders |
| 04/21/2005 | WO2003014696A3 Methods of identifying functional analogs of peptide regulators of biological pathways |
| 04/21/2005 | WO2003001182A3 Homocysteinylated transthyretin |
| 04/21/2005 | WO2002099053A3 Slc22as as modifiers of the p53 pathway and methods of use |
| 04/21/2005 | WO2002092841A3 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 04/21/2005 | US20050086711 Transgenic animals and methods for screening for anti-amyloidogenic agents and agents for treating neurodegenerative disease |
| 04/21/2005 | US20050086710 Method for generating recombinant human platelets for identifying therapeutic target proteins |
| 04/21/2005 | US20050086707 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| 04/21/2005 | US20050086083 User monitoring |
| 04/21/2005 | US20050086023 Systems and methods for predicting the bending stiffness of wood products |
| 04/21/2005 | US20050086018 Method and apparatus for estimating component concentration of a mixture |
| 04/21/2005 | US20050086011 Information processing system using nucleotide sequence-related information |
| 04/21/2005 | US20050086010 Stochastic variable selection method for model selection |
| 04/21/2005 | US20050086009 Computer implemented method and system for analyzing genetic association studies |
| 04/21/2005 | US20050086007 Method and apparatus for computer assisted analysis of compounds |
| 04/21/2005 | US20050085740 Non-invasive breath analysis using field asymmetric ion mobility spectrometry |
| 04/21/2005 | US20050085739 Visual indicating device for bad breath |
| 04/21/2005 | US20050085705 fMRI system for use in detecting neural abnormalities associated with CNS disorders and assessing the staging of such disorders |
| 04/21/2005 | US20050085630 Photocleavable isotope-coded affinity tags |
| 04/21/2005 | US20050085629 Utilization of FPRL1 as a functional receptor by serum amyloid A (SAA) |
| 04/21/2005 | US20050085627 Nucleotide sequences coding histone methyltransferase for use in identifying modulators for treatment and prevention of asthma disorders |
| 04/21/2005 | US20050085556 Generated by atherosclerosis plaque; contacting with antibody; measurement; calibration |
| 04/21/2005 | US20050085436 Administering moderator protein; antidiabetic agents |
| 04/21/2005 | US20050085421 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 04/21/2005 | US20050085418 Ligands for TGF-beta binding proteins and uses thereof |
| 04/21/2005 | US20050085411 A peptidomimetic as an antiproliferative agent |
| 04/21/2005 | US20050084983 Urine test for the diagnosis of prion diseases |
| 04/21/2005 | US20050084982 Analytical test element |
| 04/21/2005 | US20050084978 Determining concentrations of peracetic acid and hydrogen peroxide in solution by measuring redox potentials changes in a reaction mixture comprising iodide ion; bactericide and food processing |
| 04/21/2005 | US20050084977 Method and device for detecting ammonia odors and helicobacter pylori urease infection |
| 04/21/2005 | US20050084976 Measuring total gaseous mercury concentration in flue gas using filters with protective coatings which reduces chemical reactivity of gaseous mercury; pollution control |
| 04/21/2005 | US20050084953 Immunoassay element |
| 04/21/2005 | US20050084952 Apparatus for preparing an array of chemical compounds on the surface of a support; biochips |
| 04/21/2005 | US20050084935 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/21/2005 | US20050084926 Method for cell-free protein complete post-translational modification |
| 04/21/2005 | US20050084922 Fabricating reagent test strip; contacting test pad with analyte oxidizing signal producing system comprising water soluble tetrazolium salt and nitrite stabilizing agent, contact test pad to substrate, recover test strip; blood screening |
| 04/21/2005 | US20050084920 Fluorescence assay for measuring the rate of cholesterol ester transfer |
| 04/21/2005 | US20050084918 Method for the identification of agents that inhibit or promote cataracts and uses thereof |
| 04/21/2005 | US20050084917 For use in the assays, and a storage-stable standard (which may be used as a calibrator and/or control); implicated in atherosclerosis and its etiology |
| 04/21/2005 | US20050084916 Identification of the IkappaBNS protein and its products |
| 04/21/2005 | US20050084915 Using cancer screening antigen (CSA) as diagnostic/prognostic tool in detection of cell proliferative and inflammatory disorders |
| 04/21/2005 | US20050084914 Assays with primary cells |
| 04/21/2005 | US20050084913 Tumor antigen for use as tool in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 04/21/2005 | US20050084912 Method and apparatus for enhanced nano-spectroscopic scanning |
| 04/21/2005 | US20050084910 Using Fc epsilon RII receptor concentration as diagnostic indicator of food allergies, parasitic infection and inflammatory bowel disease |
| 04/21/2005 | US20050084909 Biochip for monitoring concentration of immunoglobulin in solution; bioassay; immunoassay |
| 04/21/2005 | US20050084908 Methods for detecting binding of low-molecular-weight compound and its binding partner molecule |
| 04/21/2005 | US20050084907 Using computer modeling to identify region of potential change to which to direct mutation in order to generate protein of preferential activity; directed protein evolution |
| 04/21/2005 | US20050084905 Identification of kinase inhibitors |
| 04/21/2005 | US20050084904 Mycobacterial proteins as early antigens for serodiagnosis and vaccines |
| 04/21/2005 | US20050084902 Peptide-immobilized substrate and method for measuring target protein |
| 04/21/2005 | US20050084901 Detection and quantification of prion isoforms in neurodegenerative diseases using mass spectrometry |
| 04/21/2005 | US20050084899 Compositions and methods relating to breast specific genes and proteins |
| 04/21/2005 | US20050084898 Comparative fluorescence hybridization to nucleic acid arrays |
| 04/21/2005 | US20050084897 DNA encoding human vanilloid receptor VR3 |
| 04/21/2005 | US20050084885 Modified transcription factor protein for use as tool in prevention and treatment of cell proliferative disorder |
| 04/21/2005 | US20050084879 Particle agglutination detection method and device |
| 04/21/2005 | US20050084874 Microfiltration and/or ultrafiltration process for recovery of target molecules from polydisperse liquids |
| 04/21/2005 | US20050084873 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 04/21/2005 | US20050084872 Methods for determining whether an agent possesses a defined biological activity |
| 04/21/2005 | US20050084864 Using reporter protein expression as diagnostic indicator preferential protein activity; bioassay |
| 04/21/2005 | US20050084862 Enhancing accuracy of diagnosing chlamydia infection via deoxyribonuclease digestion |
| 04/21/2005 | US20050084861 Methods of detecting modification of genetic material and monitoring processes thereof |
| 04/21/2005 | US20050084860 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 04/21/2005 | US20050084858 Method for monitoring and prognosis of disease course of gastrointestinal tumors |
| 04/21/2005 | US20050084857 Breast tumor antigen for use as tool in diagnosis prevention and treatment of mammary gland cell proliferative disorders; antitumor agents |
| 04/21/2005 | US20050084855 Using solid support comprising immobilized locked nucleic acids or peptide nucleic acid to identify preferential particles in solution |
| 04/21/2005 | US20050084854 Viral probes for use as tools in sequencing and genotyping lymphadenopathy associated viral subtypes |
| 04/21/2005 | US20050084852 Perinucleolar compartment as a cancer marker |
| 04/21/2005 | US20050084851 Classifying preferential nucleic acids via sequencing-by-synthesis; genotyping and sequence determination |
| 04/21/2005 | US20050084847 Hepatitis |
| 04/21/2005 | US20050084846 Using mucin-1 expression after exposure to interferon as prognostic tool in predicting respiratory infection |
| 04/21/2005 | US20050084845 Immunoglobulin specific to hepatitis c viral envelope protein for use as tool prevention and treatment of viral diseases |
| 04/21/2005 | US20050084843 System and method for identifying proteins involved in force-initiated signal transduction |
| 04/21/2005 | US20050084841 Using antisense agents specific to immunoglobulin superfamily genes containing leucine-rich repeat as therapeutic tool in treatment of arthritis |
| 04/21/2005 | US20050084840 Method for screening drug for improving insulin resistance |
| 04/21/2005 | US20050084506 Amide compounds such as (R)-methyl 2-(3-chloro-4-methoxybenzamido)-4-methylpentanoate and urea compounds such as 1-(2-chlorophenyl)-3-(heptan-4-yl)urea for modulating taste of food or drug products |
| 04/21/2005 | US20050084499 Comprises polypeptides for use in serodiagnosis and treatment of chlamydial sexually transmitted disease; vaccines |
| 04/21/2005 | US20050084492 Assay method to monitor the response of anti-cytokine therapy |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | US20050084451 Novel chelating agents and chelates and their use |
| 04/21/2005 | US20050084449 Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof |
| 04/21/2005 | US20050084419 Enhanced monitor system for water protection |
| 04/21/2005 | US20050083527 Disposable sensor for use in measuring an analyte in a gaseous sample |
| 04/21/2005 | US20050082944 Electromagnetic piezoelectric acoustic sensor |
| 04/21/2005 | US20050082472 Method and apparatus for monitoring the quality of lubricant |
| 04/21/2005 | US20050082207 High throughput automated seed analysis system |
| 04/21/2005 | US20050082175 Diagnosis by sensing volatile components |
| 04/21/2005 | US20050081657 Determination adsorption of odors on fabric upon storage; calibration; gas chromatography |
| 04/21/2005 | US20050081654 Lysimeter apparatus |
| 04/21/2005 | US20050081643 Multiphase coriolis flowmeter |
| 04/21/2005 | US20050081635 Measuring method, measurement-signal output circuit, and measuring apparatus |